ROLE OF PLASMA TRIGLYCERIDE IN THE REGULATION OF PLASMA LOW-DENSITY-LIPOPROTEIN (LDL) SUBFRACTIONS - RELATIVE CONTRIBUTION OF SMALL, DENSE LDL TO CORONARY HEART-DISEASE RISK

被引:450
|
作者
GRIFFIN, BA [1 ]
FREEMAN, DJ [1 ]
TAIT, GW [1 ]
THOMSON, J [1 ]
CASLAKE, MJ [1 ]
PACKARD, CJ [1 ]
SHEPHERD, J [1 ]
机构
[1] GLASGOW ROYAL INFIRM,INST BIOCHEM,GLASGOW G4 0SF,SCOTLAND
关键词
LDL SUBFRACTIONS; PLASMA TRIGLYCERIDE; CORONARY ARTERY DISEASE;
D O I
10.1016/0021-9150(94)90129-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The concentration of plasma LDL subfractions is described in four groups of normocholesterolaemic (total plasma cholesterol < 6.5 mmol/l) male subjects consisting of men with and without coronary artery disease (CAD+/-), as determined by angiography, post-myocardial infarct survivors (PMI) and normal, healthy controls. The CAD(+) and PMI groups were distinguished from the CAD(-) and controls by raised concentrations of plasma triglyceride, very low density lipoprotein (VLDL) cholesterol, small, dense LDL (LDL-III density (d) 1.044-1.060 g/ml) and lower concentrations of high density lipoprotein (HDL) cholesterol and large, buoyant LDL (LDL-I d 1.025-1.034 g/ml). In all groups, a subfraction of intermediate density, LDL-II (d 1.034-1.044 g/ml), was the predominant LDL species but was not related to coronary heart disease risk. Plasma triglyceride showed a positive association with LDL-II (r = 0.51, P < 0.001) below a triglyceride level of 1.5 mmol/l. Above this threshold of 1.5 mmol/l, LDL-II and LDL-I showed significant negative associations with triglyceride (LDL-II r = -0.5, P < 0.001; LDL-I r = -0.45, P < 0.001). Small, dense LDL-III showed a weak positive association with triglyceride that became highly significant above the 1.5 mmol/l threshold (r = 0.54, P < 0.001). While age was positively related to LDL-II within the control subjects (r = 0.3, P < 0.05), there was no difference in the percentage abundance or concentration of LDL-III within control and CAD(-) subjects above and below the age of 40 years. Smoking was associated with a relative deficiency of the LDL-I subfraction (LDL-I to LDL-III ratio in smokers = 0.77, in ex-smokers = 0.95, in non-smokers = 1.89; P < 0.01), as was beta-blocker medication (% LDL-I, users vs. non-users, P < 0.05). Both of these effects could be explained by their primary influence on plasma triglyceride. Analysis of the frequency distributions for the three LDL subfractions revealed the concentration of small, dense LDL-III to be bimodal around a concentration of 100 mg (lipoprotein mass)/100 mi plasma. The calculation of odds ratios based on this figure indicated relative risk estimates of 4.5 (chi(2): P < 0.01) for the presence of coronary artery disease and 6.9 (chi(2): P < 0.001) for myocardial infarction. These likelihood scores are greater than those previously described for LDL subclass pattern B as determined by gradient gel electrophoresis and, surprisingly, were maintained after correction for triglyceride, age, body mass index (BMI), smoking and drug status. The present study offers a quantitative description of LDL subfractions in clinically defined coronary artery disease and after myocardial infarction. It offers a plausible explanation for the underlying relationships between LDL subfractions and triglyceride that are operative in healthy and diseased individuals, and demonstrates the value of small, dense LDL as a predictive index of coronary risk status.
引用
收藏
页码:241 / 253
页数:13
相关论文
共 50 条
  • [31] PLASMA TRIGLYCERIDE AS A RISK FACTOR FOR CORONARY HEART-DISEASE - THE EPIDEMIOLOGIC EVIDENCE AND BEYOND
    AUSTIN, MA
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1989, 129 (02) : 249 - 259
  • [33] INFLUENCE OF WHOLE MILK AND ITS COMPONENTS ON PLASMA LOW-DENSITY-LIPOPROTEIN (LDL) METABOLISM IN GUINEA-PIGS
    SUN, GS
    PRICE, RL
    MCNAMARA, DJ
    FASEB JOURNAL, 1994, 8 (04): : A162 - A162
  • [34] EFFECT OF NONENZYMATIC GLYCOSYLATION OF LOW-DENSITY-LIPOPROTEIN (LDL) ON BINDING TO PURIFIED HUMAN ADIPOCYTE PLASMA-MEMBRANES
    ETCHELLS, E
    FONG, B
    ANGEL, A
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1986, 9 (03): : A35 - A35
  • [35] The role of plasma lipoprotein lipase, hepatic lipase and GPIHBP1 in the metabolism of remnant lipoproteins and small dense LDL in patients with coronary artery disease
    Muraba, Yuji
    Koga, Takafumi
    Shimomura, Yohnosuke
    Ito, Yasuki
    Hirao, Yuko
    Kobayashi, Junji
    Kimura, Takao
    Nakajima, Katsuyuki
    Murakami, Masami
    CLINICA CHIMICA ACTA, 2018, 476 : 146 - 153
  • [36] TOTAL CHOLESTEROL, LOW-DENSITY-LIPOPROTEIN CHOLESTEROL, AND HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL AND CORONARY HEART-DISEASE IN SCOTLAND
    HARGREAVES, AD
    LOGAN, RL
    THOMSON, M
    ELTON, RA
    OLIVER, MF
    RIEMERSMA, RA
    BMJ-BRITISH MEDICAL JOURNAL, 1991, 303 (6804): : 678 - 681
  • [37] The Triglyceride/High-Density Lipoprotein Cholesterol Ratio, the Small Dense Low-Density Lipoprotein Phenotype, and Ischemic Heart Disease Risk
    St-Pierre, Annie C.
    Cantin, Bernard
    Dagenais, Gilles R.
    Mauriege, Pascale
    Despres, Jean-Pierre
    Lamarche, Benoit
    METABOLIC SYNDROME AND RELATED DISORDERS, 2004, 2 (01) : 57 - 64
  • [38] Small Dense Low-Density Lipoprotein Cholesterol and the Risk of Coronary Heart Disease in a Japanese Community
    Higashioka, Mayu
    Sakata, Satoko
    Honda, Takanori
    Hata, Jun
    Yoshida, Daigo
    Hirakawa, Yoichiro
    Shibata, Mao
    Goto, Kenichi
    Kitazono, Takanari
    Osawa, Haruhiko
    Ninomiya, Toshiharu
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2020, 27 (07) : 669 - 682
  • [39] GENETIC EPIDEMIOLOGY OF LOW-DENSITY-LIPOPROTEIN SUBCLASSES - A COMMON ALLELE PREDISPOSING TO CORONARY HEART-DISEASE
    AUSTIN, MA
    KRAUSS, RM
    KING, MC
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1986, 124 (03) : 540 - 540
  • [40] IS VARIABLE INCREASE IN PLASMA CHOLESTEROL DURING CHOLESTEROL FEEDING RELATED TO DIFFERENCES IN LOW-DENSITY-LIPOPROTEIN (LDL) RECEPTOR ACTIVITY
    MISTRY, P
    HAZZARD, WR
    THOMSON, R
    BACCHUS, RA
    LEWIS, B
    CLINICAL SCIENCE AND MOLECULAR MEDICINE, 1978, 55 (03): : P12 - P12